SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (193)4/12/1999 7:51:00 AM
From: SemiBull  Read Replies (1) of 415
 
Richard,

<Sorry, thought that was you asking which product might come to clinic first. Must be two SemiBulls in the thread.>

No problem. As with most SI threads, there is so much Bull, that I get easily confused. :~)

<Sort of like asking which two of AMGN's products do you think will bring in most revenues next quarter.>

Cute. :~)

<Perhaps you're correct and the Jubak article will move the stock. Microcide was first described in an article at Microsoft Investor 4/30/97, and it was up 12% to 10 5/8 in the next nine trading days.>

So far, Jubak PR of MCDE hasn't had that same affect, but it is trading near it's 52 week low, and I jumped in again with a little more last week....so maybe with my large (:~)) investment, it will start to rise. I guess that the market was waiting for my money. :~)

Later....("the true" :~)) SemiBull
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News